On January 13, 2021, Pacific Biosciences of California, Inc., a leading provider of high-quality, long-read sequencing platforms, announced a multi-year collaboration with Invitae Corporation, a leading medical genetics company, to begin development of a production-scale high-throughput sequencing platform leveraging the power of PacBio’s highly accurate HiFi sequencing to expand Invitae’s whole genome testing capabilities. Through the collaboration, both companies will commit significant resources to support development of a production-scale sequencing platform designed with the capacity to process clinical whole genomes at scale. Those resources are expected to include talent, technology, and collaborative oversight, and Invitae will also invest capital to support development throughout the multi-year effort.

The Wilson Sonsini team that advised Pacific Biosciences in the transaction included Andrew Hoffman, Donna Petkanics, and Ian Edvalson.

For more information, please see Pacific Biosciences' press release.